Latest Posts
About This Stock
More About This Stock
Read
Read
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus
Article By:
Benzinga
Sunday, December 26, 2021 2:45 PM EDT
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key biopharma catalysts for the unfolding week.
Stocks Extend Rally As VIX Moves Lower
Article By:
Schaeffers Research
Wednesday, December 22, 2021 12:14 PM EDT
The market rebound is carrying onto Wednesday's trading, with the Dow Jones Industrial Average erasing this morning's losses to eye a 161-point pop. Both the S&P 500 Index and Nasdaq Composite (are not far behind.
Global Markets, Global News
What's your latest take on $TEVA? Also do you have an opinion on $BVXV?
BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference
Looks good. I recently started following $BVXV
BiondVax Universal Flu Vaccine Patent Granted in India
Promising news. What other countries has a patent been awarded in? $BVXV
BiondVax and NIH Sign Clinical Trial Agreement for a Phase 2 Trial in the U.S. with BiondVax's Universal Flu Vaccine
Sounds promising. $BVXV